Title	Response assessment
Number of Patients Screened	17
Number of Patients Enrolled	7
Number of Patients Evaluable for Toxicity	7
Number of Patients Evaluated for Efficacy	4
Evaluation Method	RECIST 1.1
Response Assessment CR	n = 0 (0%)
Response Assessment PR	n = 0 (0%)
Response Assessment SD	n = 1 (25%)
Response Assessment PD	n = 3 (75%)